Cationic small molecules hold great potential for preventing and treating fungal infections

May 07, 2014
Cationic small molecules hold great potential for preventing and treating fungal infections
Scanning electron microscopy images of Candida albicans biofilm before (top) and after (bottom) treatment with nanofibers produced by researchers at the A*STAR Institute of Bioengineering and Nanotechnology. Animal studies demonstrated that the nanofibers effectively eradicated C. albicans biofilm in a mouse fungal keratitis model. Credit: K. Fukushima et al.

Pathogenic fungi like Candida albicans can cause oral, skin, nail and genital infections. While exposure to pathogenic fungi is generally not life-threatening, it can be deadly to immunocompromised patients with AIDS or cancer. A variety of antifungal medications, such as triazoles and polyenes, are currently used for treating fungal infections. The range of these antifungal medications, however, is extremely limited, with some fungal species developing resistance to these drugs.

Yi Yan Yang at the A*STAR Institute of Bioengineering and Nanotechnology in Singapore and co-workers, in collaboration with IBM Almaden Research Center in the United States, have discovered four cationic terephthalamide-bisurea compounds with strong antifungal activity, excellent microbial selectivity and low host toxicity. These small molecules can self-assemble into fibers, bind fungal membrane and rupture the cells of a variety of fungal species. The results may expand the possibilities of medication for battling drug-resistant .

Conformational analysis revealed that the terephthalamide-bisurea compounds have a Z-shaped structure: the terephthalamide sits in the middle, urea groups on both sides of the terephthalamide, and cationic charges at both ends. The researchers prepared compounds with different spacers—ethyl, butyl, hexyl or benzyl amine—in-between the urea group and the cationic charge.

When dissolved in water, the terephthalamide-bisurea compounds aggregate to form fibers with lengths ranging from a few hundred nanometers to several micrometers. Some of the compounds form fibers with high flexibility and others with high rigidity.

The researchers evaluated the antifungal activity of their terephthalamide-bisurea compounds against C. albicans. They found that all of the cationic compounds effectively inhibited , even when the fungal concentration increased from 102 to 105 colony-forming units per milliliter.

The researchers believe that the potent antifungal activity is largely due to the formation of fibers with extremely small diameters in the order of 5 to 10 nanometers, which facilitates the rupture of fungal membranes. "This is particularly important because the fungal membrane of C. albicans is multilayered and has low negative charges," explains Yang. "It also helps explain why cationic terephthalamide-bisurea compounds could easily penetrate the fungal membrane."

The terephthalamide-bisurea compounds also eradicated clinically isolated drug-resistant C. albicans. The compounds prevent the development of drug resistance by rupturing the fungal membrane of C. albicans and disrupting the biofilm (see image).

Additionally, cytotoxicity tests showed that the cationic terephthalamide-bisurea compounds exhibit low toxicity toward mammalian cells and in a mouse model, revealing that the "are relatively safe for preventing and treating ," says Yang.

Explore further: Converting recycled plastics into disease-fighting nanofibers

More information: Fukushima, K., Liu, S., Wu, H., Engler, A. C., Coady, D. J. et al. "Supramolecular high-aspect ratio assemblies with strong antifungal activity." Nature Communications 4, 2861 (2013). dx.doi.org/10.1038/ncomms3861

add to favorites email to friend print save as pdf

Related Stories

Fatal fungal infections resist newest class of drugs

Sep 07, 2011

Fungi that cause severe infections in those with compromised immune systems are resisting the action of the latest group of antifungal drugs. Uncovering their strategies for doing this will lead to more effective treatments, ...

Recommended for you

YEATS protein potential therapeutic target for cancer

1 hour ago

Federal Express and UPS are no match for the human body when it comes to distribution. There exists in cancer biology an impressive packaging and delivery system that influences whether your body will develop cancer or not.

Precise and programmable biological circuits

3 hours ago

A team led by ETH professor Yaakov Benenson has developed several new components for biological circuits. These components are key building blocks for constructing precisely functioning and programmable bio-computers.

User comments : 0